At Quell, we aim to provide truly groundbreaking and life-altering treatments for our patients. Our goal as an organization is to establish a prominent global biopharmaceutical firm that offers revolutionary and highly esteemed therapies for various autoimmune and inflammatory conditions, as well as for preventing organ transplant rejection, using modular engineered Tregs. Quell is dedicated to delivering treatments that are highly regarded by doctors, patients, and payors, and show the potential to bring about transformative outcomes for our patients.